Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Hanover Media Strategy Limited naming Stephen Donnelly .
Filed returns
18
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2023 | Hanover Media Strategy Limited | Health | Influenza vaccination campaign (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2023 | Hanover Media Strategy Limited | Health | Influenza vaccination campaign. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2023 | Hanover Media Strategy Limited | Health | Discussion on the level of influenza vaccine protection for the over 65 population in Ireland. (Public policy or programme) | 23 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Energy and Natural Resources | Ocean Winds' offshore wind projects in Ireland (Zoning or development) | 62 | On lobbying.ie |
| Jan–Apr 2022 | Hanover Media Strategy Limited | Health | Introducing Horizon and its presence in Ireland (Public policy or programme) | 16 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Partnership for Health System Sustainability and Resilience (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2021 | Hanover Media Strategy Limited | Health | Update on AstraZeneca COVID-19 vaccine and therapies (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Update on COVID-19 Vaccine AstraZeneca (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Medicines Access for Irish patients with rare diseases (Legislation) | 1 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Update on COVID-19 Vaccine AstraZeneca (Public policy or programme) | 15 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 15 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 14 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Briefed select parliamentarians on potential Covid-19 vaccine (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Update on potential COVID-19 Vaccine (Matters involving public funds) | 4 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 16 | On lobbying.ie |
| Jan–Apr 2020 | Hanover Media Strategy Limited | Transport | The impact of COVID-19 on the tourism sector in Ireland, and the specific impact it is having the Irish car rental industry (Legislation) | 20 | On lobbying.ie |
| Jan–Apr 2020 | Hanover Media Strategy Limited | Health | Optimisation of Rheumatoid Arthritis pathway of care (Matters involving public funds) | 10 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 16 | 88.9% | |
| Energy and Natural Resources | 1 | 5.6% | |
| Transport | 1 | 5.6% |